Rangebound since January, will earnings be the much needed catalyst?

Sanofi has been rangebound since the start of this year, the range is highlighted using the blue channel with a low of €84.94 and a high of €94.92. Thus far, it is unclear in what direction the price may head towards, perhaps the earnings tomorrow will be the new catalyst for this stock as we enter H2. Its share price floats around €92.12 with key resistance at €96.50 and key support at €84.94. The stock does seem to have an established supportive trendline which dates back to 2018, this could prove robust if the earnings force a sell-off towards it. At the moment trendline support reads around €83.73 and may be tested if a fall below €84.94 occurs. Towards the upside, a clear break above €96.50 is needed for a potential take-off towards the decade's highs. The technical indicators do not offer any guidance as their positioning is similar to rangebound moves over the last 6 months. Most likely adjusting for a reaction following the earnings. The firm is expected to report earnings per share of €1.65 on revenue of €10.79bn.